PD patients exhibit an impaired immune response with the contribution of monocytes, CD4 + cells, regulatory T cells, and increased circulatory cytokines (TNF, IFNγ, IL-1β, IL-6, IL-2) (Tansey et al. 2022). Here, IL1B is linked to Parkinson disease.